Andrea Martinez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Andrea Martinez has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Alexis Okoh
Emory Department of Medicine, Division of Cardiology, Atlanta, GA, USA
2 shared publications- Arash Harzand
Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA
1 shared publication - Bryan J. Wells
Emory University School of Medicine
1 shared publication Bryan Wells
Emory University School of Medicine
1 shared publicationCian P. McCarthy
Heart and Vascular Institute, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA; Baim Institute for Clinical Research, Brookline, Massachusetts, USA
1 shared publicationDavid Cheng
Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Biostatistics Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Mongan Institute, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA
1 shared publication
Latest Publications
- 30 April 2024
- Published by SAGE Publications in Vascular Medicine
- Vol. 29 (3) , 309-312
Racial differences in fibromuscular dysplasia (FMD)
- 30 April 2024
- Published by SAGE Publications in Vascular Medicine
- Vol. 29 (3) , 309-312
Racial differences in fibromuscular dysplasia (FMD)
- Open Access
- 23 February 2024
- Published by Radcliffe Medical Media Ltd in US Cardiology Review
- Vol. 18, e04
The Pink Tax: Sex and Gender Disparities in Peripheral Artery Disease
Peripheral artery disease (PAD) is an atherosclerotic disease associated with significant functional impairment, morbidity, and mortality. Among women, PAD remains poorly recognized and undermanaged. Compared with men, women with PAD tend to be underdiagnosed or misdiagnosed, have poorer quality of life, and experience higher rates of PAD-related morbidity and cardiovascular mortality. In this review, we describe the sex- and gender-related differences in the epidemiology, presentation, diagnosis, and management of PAD. We provide specific recommendations to overcome these factors, including greater awareness and an increased emphasis on tailored and more aggressive interventions for women with PAD. Such changes are warranted and necessary to achieve more equitable outcomes in women with PAD, including improved limb outcomes, enhanced lifestyle, and cardiovascular risk reduction.
- 23 February 2024
- Published by Radcliffe Medical Media Ltd in US Cardiology Review
- Vol. 18, e04
Open AccessThe Pink Tax: Sex and Gender Disparities in Peripheral Artery Disease
Peripheral artery disease (PAD) is an atherosclerotic disease associated with significant functional impairment, morbidity, and mortality. Among women, PAD remains poorly recognized and undermanaged. Compared with men, women with PAD tend to be underdiagnosed or misdiagnosed, have poorer quality of life, and experience higher rates of PAD-related morbidity and cardiovascular mortality. In this review, we describe the sex- and gender-related differences in the epidemiology, presentation, diagnosis, and management of PAD. We provide specific recommendations to overcome these factors, including greater awareness and an increased emphasis on tailored and more aggressive interventions for women with PAD. Such changes are warranted and necessary to achieve more equitable outcomes in women with PAD, including improved limb outcomes, enhanced lifestyle, and cardiovascular risk reduction.
- Open Access
Racial Differences in FMD
Background Fibromuscular dysplasia (FMD) is a non-atherosclerotic arteriopathy associated with stenosis, aneurysm, and dissection. We aimed to characterize racial differences in clinical presentation and diagnosis among patients with FMD at our institution. Methods We utilized an ambulatory FMD database to review demographics, clinical presentation, and diagnostic assessments of patients diagnosed with FMD within a university-affiliated healthcare system. Patients were classified as White or Non-White based on self-identified race. We evaluated race-specific differences in diagnosis and disease manifestations. Results A total of 208 patients (White: n=160 (77%); Non-White; n=48 (23%)) were included in the analysis. The time from initial FMD symptom to diagnosis was longer in Non-Whites than Whites (5.5 vs. 1.5 yrs; pConclusion We found racial differences in the diagnosis of FMD. The time from symptom onset to diagnosis was longer in Non-White than White FMD patients. Multimodality diagnostic imaging was more often utilized in Whites than Non-Whites. Research is needed to investigate these racial differences.
Open AccessRacial Differences in FMD
Background Fibromuscular dysplasia (FMD) is a non-atherosclerotic arteriopathy associated with stenosis, aneurysm, and dissection. We aimed to characterize racial differences in clinical presentation and diagnosis among patients with FMD at our institution. Methods We utilized an ambulatory FMD database to review demographics, clinical presentation, and diagnostic assessments of patients diagnosed with FMD within a university-affiliated healthcare system. Patients were classified as White or Non-White based on self-identified race. We evaluated race-specific differences in diagnosis and disease manifestations. Results A total of 208 patients (White: n=160 (77%); Non-White; n=48 (23%)) were included in the analysis. The time from initial FMD symptom to diagnosis was longer in Non-Whites than Whites (5.5 vs. 1.5 yrs; pConclusion We found racial differences in the diagnosis of FMD. The time from symptom onset to diagnosis was longer in Non-White than White FMD patients. Multimodality diagnostic imaging was more often utilized in Whites than Non-Whites. Research is needed to investigate these racial differences.